• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在二乙基亚硝胺(DEN)-四氯化碳(CCl)诱导的肝纤维化小鼠模型中,向纤维化和肝细胞癌的进展与巨噬细胞及显著的调节性T细胞浸润有关。

Progression to fibrosis and hepatocellular carcinoma in DEN CCl liver mice, is associated with macrophage and striking regulatory T cells infiltration.

作者信息

Ajith Ananya, Evraerts Jonathan, Bouzin Caroline, Brusa Davide, Merimi Makram, Najar Mehdi, Smets Françoise, Sokal Etienne, Najimi Mustapha

机构信息

Laboratory of Pediatric Hepatology and Cell Therapy, Institute of Experimental and Clinical Research, Université catholique de Louvain (UCLouvain), Brussels, Belgium.

Institut de Recherche Expérimentale et Clinique (IREC) Imaging Platform (2IP), Institute of Experimental and Clinical Research, Université catholique de Louvain (UCLouvain), Brussels, Belgium.

出版信息

Front Immunol. 2025 Jul 8;16:1601215. doi: 10.3389/fimmu.2025.1601215. eCollection 2025.

DOI:10.3389/fimmu.2025.1601215
PMID:40698077
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12279789/
Abstract

BACKGROUND AND AIM

Hepatocellular carcinoma (HCC) is a classic inflammation related cancer with most cases arising from chronic liver disease (CLD). This study investigates immune dysregulation that occurs during the progression of CLD to HCC by delineating changes in immune cell composition and distribution within the liver microenvironment.

METHODS

Mice were injected with Diethylnitrosamine (DEN) at 4 weeks of age, followed by continuous tri-weekly injections of carbon tetrachloride (CCl) for 6 and 21 weeks to induce liver fibrosis and HCC. Naïve and Phosphate-buffered saline (PBS) corn oil treated mice were used as controls. Immune cell profiling was performed using multiplex immunofluorescence and flow cytometry analyses.

RESULTS

The spatial analysis of immune cell populations in HCC reveals stable leukocytes overall, with notable increases in myeloid cells, particularly infiltrating macrophages (Inf mph). Indeed, Inf mph show a progressive enrichment from control to tumor, reaching a 5-fold and 10-fold increase in the invasive margin (IM) and surrounding non-tumor tissue (NTT) regions, respectively. T lymphocytes, especially CD4+ T cells but not CD8+ T cells, significantly expand, with CD4+ cells increasing up to 10-fold in the IM and NTT regions of HCC livers. Regulatory T cells (Tregs) population exhibits an extraordinary 125-fold and 80-fold surge in the IM and NTT regions, respectively.

CONCLUSIONS

The DEN-CCl induced HCC mouse model replicates key immunosuppressive features of human HCC, notably increased Tregs and macrophages, which provides a robust platform for testing immunotherapies. The prominence of immune cells in the IM region underscores its importance as a critical interface modulating tumor-immune interactions, while the elevated immune presence in the NTT region reflects broader immune dysregulation associated with advanced CLD, and potentially facilitating tumor progression.

摘要

背景与目的

肝细胞癌(HCC)是一种典型的炎症相关癌症,大多数病例源于慢性肝病(CLD)。本研究通过描绘肝微环境中免疫细胞组成和分布的变化,调查CLD进展为HCC过程中发生的免疫失调。

方法

4周龄小鼠注射二乙基亚硝胺(DEN),随后连续三周一次注射四氯化碳(CCl),持续6周和21周以诱导肝纤维化和HCC。未处理和用磷酸盐缓冲盐水(PBS)玉米油处理的小鼠用作对照。使用多重免疫荧光和流式细胞术分析进行免疫细胞谱分析。

结果

HCC中免疫细胞群体的空间分析显示总体白细胞稳定,髓系细胞显著增加,特别是浸润性巨噬细胞(Inf mph)。事实上,Inf mph从对照到肿瘤呈现逐渐富集,在侵袭边缘(IM)和周围非肿瘤组织(NTT)区域分别增加了5倍和10倍。T淋巴细胞,尤其是CD4 + T细胞而非CD8 + T细胞显著扩增,CD4 +细胞在HCC肝脏的IM和NTT区域增加高达10倍。调节性T细胞(Tregs)群体在IM和NTT区域分别出现了高达125倍和80倍的激增。

结论

DEN - CCl诱导的HCC小鼠模型复制了人类HCC的关键免疫抑制特征,特别是Tregs和巨噬细胞增加,这为测试免疫疗法提供了一个强大的平台。IM区域免疫细胞的突出强调了其作为调节肿瘤 - 免疫相互作用的关键界面的重要性,而NTT区域免疫存在的升高反映了与晚期CLD相关的更广泛的免疫失调,并可能促进肿瘤进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/418e/12279789/faa95c741780/fimmu-16-1601215-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/418e/12279789/7e5a1454f00c/fimmu-16-1601215-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/418e/12279789/52210b7df8e7/fimmu-16-1601215-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/418e/12279789/ac7d14b29e5b/fimmu-16-1601215-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/418e/12279789/428330488e92/fimmu-16-1601215-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/418e/12279789/d6dd58798f2a/fimmu-16-1601215-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/418e/12279789/faa95c741780/fimmu-16-1601215-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/418e/12279789/7e5a1454f00c/fimmu-16-1601215-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/418e/12279789/52210b7df8e7/fimmu-16-1601215-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/418e/12279789/ac7d14b29e5b/fimmu-16-1601215-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/418e/12279789/428330488e92/fimmu-16-1601215-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/418e/12279789/d6dd58798f2a/fimmu-16-1601215-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/418e/12279789/faa95c741780/fimmu-16-1601215-g006.jpg

相似文献

1
Progression to fibrosis and hepatocellular carcinoma in DEN CCl liver mice, is associated with macrophage and striking regulatory T cells infiltration.在二乙基亚硝胺(DEN)-四氯化碳(CCl)诱导的肝纤维化小鼠模型中,向纤维化和肝细胞癌的进展与巨噬细胞及显著的调节性T细胞浸润有关。
Front Immunol. 2025 Jul 8;16:1601215. doi: 10.3389/fimmu.2025.1601215. eCollection 2025.
2
Liver fibrosis promotes immune escape in hepatocellular carcinoma via GOLM1-mediated PD-L1 upregulation.肝纤维化通过 GOLM1 介导的 PD-L1 上调促进肝癌中的免疫逃逸。
Cancer Lett. 2021 Aug 10;513:14-25. doi: 10.1016/j.canlet.2021.05.007. Epub 2021 May 14.
3
Hepatic inflammation-fibrosis-cancer axis in the rat hepatocellular carcinoma induced by diethylnitrosamine.二乙基亚硝胺诱导的大鼠肝细胞癌中的肝脏炎症-纤维化-癌症轴
J Cancer Res Clin Oncol. 2017 May;143(5):821-834. doi: 10.1007/s00432-017-2364-z. Epub 2017 Feb 25.
4
Platelet C3G protects from liver fibrosis, while enhancing tumor growth through regulation of the immune response.血小板C3G可预防肝纤维化,同时通过调节免疫反应促进肿瘤生长。
J Pathol. 2025 Apr;265(4):502-517. doi: 10.1002/path.6403. Epub 2025 Feb 24.
5
Ganoderic acid A regulates CSF1R to reprogram tumor-associated macrophages for immune therapy of hepatocellular carcinoma.灵芝酸A通过调节集落刺激因子1受体对肿瘤相关巨噬细胞进行重编程,用于肝细胞癌的免疫治疗。
Int Immunopharmacol. 2025 Aug 28;161:114989. doi: 10.1016/j.intimp.2025.114989. Epub 2025 Jun 7.
6
Lymphocyte exhaustion in hepatocellular carcinoma: a dynamic evolution across disease stages.肝细胞癌中的淋巴细胞耗竭:疾病各阶段的动态演变
Front Immunol. 2025 Jun 6;16:1611365. doi: 10.3389/fimmu.2025.1611365. eCollection 2025.
7
Liensinine reshapes the immune microenvironment and enhances immunotherapy by reprogramming metabolism through the AMPK-HIF-1α axis in hepatocellular carcinoma.莲心碱通过激活腺苷酸活化蛋白激酶-低氧诱导因子-1α轴重编程代谢,重塑免疫微环境并增强肝细胞癌的免疫治疗效果。
J Exp Clin Cancer Res. 2025 Jul 15;44(1):208. doi: 10.1186/s13046-025-03477-6.
8
Increased prevalence of regulatory T cells in the tumor microenvironment and its correlation with TNM stage of hepatocellular carcinoma.肿瘤微环境中调节性 T 细胞的增加及其与肝癌 TNM 分期的相关性。
J Cancer Res Clin Oncol. 2010 Nov;136(11):1745-54. doi: 10.1007/s00432-010-0833-8. Epub 2010 Mar 10.
9
Chemoresistance and immune evasion in hepatocellular carcinoma: the role of miRNA-425-5p.肝细胞癌中的化疗耐药与免疫逃逸:miRNA-425-5p的作用
Carcinogenesis. 2025 Apr 3;46(2). doi: 10.1093/carcin/bgaf012.
10
Modified mesenchymal stromal cells by in vitro transcribed mRNA: a therapeutic strategy for hepatocellular carcinoma.经体外转录 mRNA 修饰的间充质基质细胞:肝细胞癌的治疗策略。
Stem Cell Res Ther. 2024 Jul 11;15(1):208. doi: 10.1186/s13287-024-03806-0.

本文引用的文献

1
Comprehensive Analysis of the Immunosuppressive Function of Regulatory T Cells in Human Hepatocellular Carcinoma Tissues.调控性 T 细胞在人肝癌组织中免疫抑制功能的综合分析。
Cancer Control. 2024 Jan-Dec;31:10732748241251580. doi: 10.1177/10732748241251580.
2
Proteomic analysis of DEN and CCl-induced hepatocellular carcinoma mouse model.DEN 和 CCl 诱导的肝癌小鼠模型的蛋白质组学分析。
Sci Rep. 2024 Apr 5;14(1):8013. doi: 10.1038/s41598-024-58587-6.
3
A key driver to promote HCC: Cellular crosstalk in tumor microenvironment.
促进肝癌发生的一个关键驱动因素:肿瘤微环境中的细胞间相互作用。
Front Oncol. 2023 Mar 15;13:1135122. doi: 10.3389/fonc.2023.1135122. eCollection 2023.
4
Regulatory T cells and their associated factors in hepatocellular carcinoma development and therapy.调节性 T 细胞及其相关因素在肝细胞癌发生和治疗中的作用。
World J Gastroenterol. 2022 Jul 21;28(27):3346-3358. doi: 10.3748/wjg.v28.i27.3346.
5
Tumor-associated macrophages in liver cancer: From mechanisms to therapy.肝癌相关巨噬细胞:从机制到治疗。
Cancer Commun (Lond). 2022 Nov;42(11):1112-1140. doi: 10.1002/cac2.12345. Epub 2022 Sep 7.
6
Approaches to spatially resolving the tumour immune microenvironment of hepatocellular carcinoma.解析肝细胞癌肿瘤免疫微环境空间特征的方法
Ther Adv Med Oncol. 2022 Jul 22;14:17588359221113270. doi: 10.1177/17588359221113270. eCollection 2022.
7
Chemokine CXCL10 Modulates the Tumor Microenvironment of Fibrosis-Associated Hepatocellular Carcinoma.趋化因子 CXCL10 调节纤维相关型肝细胞癌的肿瘤微环境。
Int J Mol Sci. 2022 Jul 23;23(15):8112. doi: 10.3390/ijms23158112.
8
The risk of hepatocellular carcinoma in cirrhosis differs by etiology, age and sex: A Swedish nationwide population-based cohort study.肝硬化中肝细胞癌的风险因病因、年龄和性别而异:一项瑞典全国基于人群的队列研究。
United European Gastroenterol J. 2022 Jun;10(5):465-476. doi: 10.1002/ueg2.12238. Epub 2022 May 1.
9
T- and B-Cells in the Inner Invasive Margin of Hepatocellular Carcinoma after Resection Associate with Favorable Prognosis.肝癌切除术后肿瘤内侵袭边缘的T细胞和B细胞与良好预后相关。
Cancers (Basel). 2022 Jan 25;14(3):604. doi: 10.3390/cancers14030604.
10
Infiltrating regulatory T cells promote invasiveness of liver cancer cells via inducing epithelial-mesenchymal transition.浸润性调节性T细胞通过诱导上皮-间质转化促进肝癌细胞的侵袭性。
Transl Cancer Res. 2019 Oct;8(6):2405-2415. doi: 10.21037/tcr.2019.09.54.